HIGHFDA DRUG

Major Pharmaceuticals Chlorpromazine Hydrochloride 50 mg Tablets Recalled for Nitrosamine Impurity (

Major Pharmaceuticals, via The Harvard Drug Group LLC, recalled 506 blister packs of Chlorpromazine Hydrochloride tablets, 50 mg, distributed nationwide. A CGMP deviation shows the presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit. Stop using the product and contact the Harvard Drug Group or Rugby Laboratories for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
September 12, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
September 12, 2025
Hazard Level
HIGH
Brands
Major Pharmaceuticals, Chlorpromazine Hydrochloride
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Major Pharmaceuticals, Chlorpromazine Hydrochloride
Product type
Chlorpromazine Hydrochloride Tablets, 50 mg
Model numbers
N02009, N02026
UPC codes
0904-7129, 0904-7130, 0904-7131, 0904-7132, 0904-7133, 0904-7129-61, 0904-7130-61, 0904-7130-06 +4 more
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 12, 2025

  2. Reported by FDA DRUG

    October 15, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories or your healthcare provider for guidance. Notification method: Letter

About This Product

Chlorpromazine hydrochloride is a prescription antipsychotic used for certain psychiatric conditions. The recalled lots were packaged as 50 mg tablets in 10x10 blister packs and distributed nationwide.

Why This Is Dangerous

The impurity N-Nitroso Desmethyl Chlorpromazine was found above the recommended intake limit due to CGMP deviations in manufacturing. Prolonged exposure to nitrosamine impurities can pose health risks.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers prescribed this drug should stop using the affected lots and contact their healthcare provider. The recall covers 506 blister packs nationwide and may affect patients who rely on this medication for treatment.

Practical Guidance

How to identify if yours is affected

  1. Check NDC 0904-7131-61 on the bottle label.
  2. Verify model numbers N02009 or N02026 on the packaging.
  3. Look for 50 mg dosage in a (10x10) blister pack.
  4. Confirm packaging type and UPC if present.

Where to find product info

FDA enforcement page for recall D-0011-2026 and the distributor’s recall notice.

What timeline to expect

Refunds or replacements, if offered, typically take 4-8 weeks.

If the manufacturer is unresponsive

  • Document all contact attempts with the distributor.
  • File a complaint with the FDA or state consumer protection agency if no response is received.
  • Consult your healthcare provider for interim alternatives.

How to prevent similar issues

  • When buying prescription medications, verify CGMP compliance and recall status.
  • Check NDC codes before use.
  • Keep packaging and recall notices until resolved.

Documentation advice

Retain the product packaging, recall notice, and any correspondence with the distributor and your healthcare provider for records.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Model numbers: N02009, N02026. NDC: 0904-7131-61. UPC: (01)00309047131617. Quantity: 506 blister packs. Distribution: Nationwide. Sold at: Unknown. Price: Unknown.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 506 blister packs recalled
  • Model numbers N02009 and N02026
  • Nitrosamine impurity above intake limit
  • No injuries reported

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
POISONING

Product Classification

Product Details

Model Numbers
N02009
N02026
UPC Codes
0904-7129
0904-7130
0904-7131
+9 more
Affected States
ALL
Report Date
October 15, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls